NTES [NetEase] SC 13G/A: (1) This CUSIP number applies to the Issuers
[(1) This CUSIP number applies to the Issuers American depositary shares, each representing 25 ordinary shares. CUSIP No. 64110W102 13G]
JOBS [51JOB] SC 13G/A: Harding Loevner LP I.R.S. IDENTIFICATION NO. OF ABOVE
[Harding Loevner LP I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) 27-068-4167 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 4,03]
BABA [Alibaba] SC 13G/A: SCHEDULE 13G (Amendment No. 4)* Alibaba Group Holding
[SCHEDULE 13G (Amendment No. 4)* Alibaba Group Holding Limited (Name of Issuer) American Depositary Shares (ADS), each representing one ordinary share, par value $0.000025 per share (Title of Class of Securities) 01609W102** (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of thi]
CTRP [CTRIP COM INTERNATIONAL] SC 13G/A: 1. Name of Reporting Person T. ROWE PRICE
[1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 1,005,681 ]
CJJD [CHINA JO-JO DRUGSTORES] 8-K: China Jo-Jo Drugstores Reports Third Quarter 2019 Financial
[China Jo-Jo Drugstores Reports Third Quarter 2019 Financial Results HANGZHOU, China, Feb. 14, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare pr]
BABA [Alibaba] SC 13G: (Original Filing)
[JOINT FILING AGREEMENT Dated: February 14, 2019 Alibaba Group Holding Limited Taobao Holding Limited Taobao China Holding Limited] [13G CUSIP No. G10970112; 090040106]
CO [Global Cord Blood] SC 13G/A: (Original Filing)
[SCHEDULE 13G/A Amendment No. 14 Global Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *]
KANG [iKang Healthcare] SC 13G/A: (Original Filing)
[SCHEDULE 13G (Amendment No. __3______)* iKang Healthcare Group, Inc. (Name of Issuer) Class A common shares, par value US$0.01 per share, including in the form of American Depositary Shares (each representing 1/2 of a Class A common share) (Title of Class of Securities) 45174L108 (CUSIP Number) Dece]
BABA [Alibaba] 13F-HR: (Original Filing)
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;} .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;} .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, s]
WB [WEIBO] SC 13G/A: (Original Filing)
[Harding Loevner LP I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) 27-068-4167 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 2,26]
